Patch for topical application on localized eczema.

Relief form itching and protection from scratching in atopic dermatitis especially for children.

Indication: Atopic dermatitis, common eczema, itchy red scaling skin. Drug substances: Polidocanol, cooling agent, emollient. Advantage of the product: The patch gives relief from itching and protects against scratching. Thereby the scratching- itching-scratching-cycle is broken. Furthermore the hydration of the skin is improved through the emollient. All excipients are antiallergen and non-irritating. The product is safe. There is no systemical drug application. Status: The formulation is developed, samples are manufactured and tested in humans. The Product can be filed as medical device class I or as cosmetic product. Registration files will be available 3 month's after upscale to production scale.

Phase II

Patent application pending world wide

Licensing worldwide.